Okita, G., Suenaga, K., Sakaguchi, M., & Murakami, T. (2025). A novel oncolytic vaccinia virus with multiple gene modifications involved in viral replication and maturation increases safety for intravenous administration while maintaining proliferative potential in cancer cells. PLoS ONE, 20(3), 1. https://doi.org/10.1371/journal.pone.0312205
Chicago Style (17th ed.) CitationOkita, Go, Kiyotaka Suenaga, Masashi Sakaguchi, and Toshio Murakami. "A Novel Oncolytic Vaccinia Virus with Multiple Gene Modifications Involved in Viral Replication and Maturation Increases Safety for Intravenous Administration While Maintaining Proliferative Potential in Cancer Cells." PLoS ONE 20, no. 3 (2025): 1. https://doi.org/10.1371/journal.pone.0312205.
MLA (9th ed.) CitationOkita, Go, et al. "A Novel Oncolytic Vaccinia Virus with Multiple Gene Modifications Involved in Viral Replication and Maturation Increases Safety for Intravenous Administration While Maintaining Proliferative Potential in Cancer Cells." PLoS ONE, vol. 20, no. 3, 2025, p. 1, https://doi.org/10.1371/journal.pone.0312205.